Pancreatic cancer is one of the most lethal form of cancers,
which was characterized by high rates of local recurrence.26
Because of late diagnosis and lack of chemotherapy response,
the 5-year survival rate for pancreatic cancer has still less than
5%. Currently, only gemcitabine and fluorouracil have been
used consistently to improve the survival of pancreatic patients
with marginal survival advantage.